Federico A - Search Results

1

Cerebrotendinous xanthomatosis as a multisystem disease mimicking premature ageing.

Dotti MT, Salen G, Federico A. Dotti MT, et al. Among authors: federico a. Dev Neurosci. 1991;13(4-5):371-6. doi: 10.1159/000112187. Dev Neurosci. 1991. PMID: 1817044 Review.

2

Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy.

Federico A, Dotti MT. Federico A, et al. J Child Neurol. 2003 Sep;18(9):633-8. doi: 10.1177/08830738030180091001. J Child Neurol. 2003. PMID: 14572142 Review.

3

Mitochondrial enzyme deficiency in cerebrotendinous xanthomatosis.

Dotti MT, Manneschi L, Federico A. Dotti MT, et al. Among authors: federico a. J Neurol Sci. 1995 Apr;129(2):106-8. doi: 10.1016/0022-510x(94)00256-n. J Neurol Sci. 1995. PMID: 7608723

4

Cerebrotendinous xanthomatosis (van Bogaert-Scherer-Epstein disease): CT and MR findings.

Dotti MT, Federico A, Signorini E, Caputo N, Venturi C, Filosomi G, Guazzi GC. Dotti MT, et al. Among authors: federico a. AJNR Am J Neuroradiol. 1994 Oct;15(9):1721-6. AJNR Am J Neuroradiol. 1994. PMID: 7847220 Free PMC article. Review.

5

Cerebrotendinous xanthomatosis: pathophysiological study on bone metabolism.

Federico A, Dotti MT, Loré F, Nuti R. Federico A, et al. J Neurol Sci. 1993 Mar;115(1):67-70. doi: 10.1016/0022-510x(93)90068-a. J Neurol Sci. 1993. PMID: 8468594

6

Cerebrotendinous xanthomatosis: 11-year treatment with chenodeoxycholic acid in five patients. An electrophysiological study.

Mondelli M, Sicurelli F, Scarpini C, Dotti MT, Federico A. Mondelli M, et al. Among authors: federico a. J Neurol Sci. 2001 Sep 15;190(1-2):29-33. doi: 10.1016/s0022-510x(01)00563-9. J Neurol Sci. 2001. PMID: 11574103 Clinical Trial.

7

Normalisation of serum cholestanol concentration in a patient with cerebrotendinous xanthomatosis by combined treatment with chenodeoxycholic acid, simvastatin and LDL apheresis.

Dotti MT, Lütjohann D, von Bergmann K, Federico A. Dotti MT, et al. Among authors: federico a. Neurol Sci. 2004 Oct;25(4):185-91. doi: 10.1007/s10072-004-0320-6. Neurol Sci. 2004. PMID: 15549503

8

Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid.

Ginanneschi F, Mignarri A, Mondelli M, Gallus GN, Del Puppo M, Giorgi S, Federico A, Rossi A, Dotti MT. Ginanneschi F, et al. Among authors: federico a. J Neurol. 2013 Jan;260(1):268-74. doi: 10.1007/s00415-012-6630-3. Epub 2012 Aug 10. J Neurol. 2013. PMID: 22878431

9

Evoked potentials in cerebrotendinous xanthomatosis and effect induced by chenodeoxycholic acid.

Mondelli M, Rossi A, Scarpini C, Dotti MT, Federico A. Mondelli M, et al. Among authors: federico a. Arch Neurol. 1992 May;49(5):469-75. doi: 10.1001/archneur.1992.00530290051011. Arch Neurol. 1992. PMID: 1316120

10

Quantification of brain damage in cerebrotendinous xanthomatosis with magnetization transfer MR imaging.

Inglese M, De Stefano N, Pagani E, Dotti MT, Comi G, Federico A, Filippi M. Inglese M, et al. Among authors: federico a. AJNR Am J Neuroradiol. 2003 Mar;24(3):495-500. AJNR Am J Neuroradiol. 2003. PMID: 12637303 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,173 results

Search Page

Filters